Acurx Pharmaceuticals, Inc. (ACXP)
1.66
+0.04
(+2.47%)
USD |
NASDAQ |
Jun 09, 16:00
1.66
0.00 (0.00%)
After-Hours: 20:00
Acurx Pharmaceuticals EPS Diluted (Quarterly) : -0.6184 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| KalVista Pharmaceuticals, Inc. | -0.4303 |
| Kala Bio, Inc. | -0.1365 |
| Sensei Biotherapeutics, Inc. | -3.622 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.681M |
| Total Expenses (Quarterly) | 1.681M |
| Enterprise Value | -3.764M |
| Earnings Yield | -265.3% |
| Normalized Earnings Yield | -265.27 |